Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:22 Aug 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1560.05 [ -0.28% ]TCS 2497.55 [ -1.24% ]

Sensex31291.85
33.00 0.11%

Nifty9765.55
11.20 0.11%

Midcap14925.89
-61.54 -0.41%

Smallcap15410.18
-48.91 -0.32%



Alembic Pharmaceuticals Ltd :

 511.90  -2.30 [-0.45%]

ISIN: INE901L01018  | NSE: APLLTD |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 533573  |  Add To Watchlist

Price Information
• Open 515.50
• High 520.00
• Low 507.00
• Previous Close 514.20
• Shares Traded 249500
• 52 Wk High Price 709.30
• 52 Wk High Date 23-03-2017
• 52 Wk Low Price 492.25
• 52 Wk Low Date 27-06-2017
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 9718.12
• EPS (Rs.)(TTM) 19.18
• P/E Ratio(TTM) 26.90
• Book Value (Rs.) 99.10
• Price to Book Value 5.21
• Equity (Rs.cr.) 37.70
• Traded Value (Rs.lac) 13.82


Corporate Actions
Ex-Date Purpose (Rs.)
2012-07-31 70% Dividend (1.4)
2013-07-29 125% Dividend (2.5)
2014-07-17 150% Dividend (3)
2015-07-22 175% Dividend (3.5)
2016-07-20 200% Dividend (4)
2017-07-11 200% Dividend (4)


Index Names
BSE HC
BSE Small Cap
BSE-500
BSE-200


Related Companies
Stock Name Price
BAJAJTEMPO 3808.00




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Jun, 2017 Jun, 2017 Mar, 2017
• Sales (Rs.cr) 590.11 2878.66 2985.90
• Net Profit (Rs.cr) 50.66 361.55 430.63
• Net Profit Var (%) -58.00 -51.00 -38.00
• EPS (Rs) - 19.18 22.00
• P/E Ratio - 26.90 23.40
• Operating Profit Margin - 19.04 -
• CPS (Rs.) - - 26.40
• P/C Ratio - - 19.50
• Div% - - 200.00

Announcements
28-04-2016 Board of Alembic Pharmaceuticals recommends final dividend
29-06-2012 Alembic and Breckenridge announce paragraph IV ANDA litigation with Pfizer on desvenlafaxine (Prist
15-06-2012 Alembic Pharma settles patent litigation with Novartis for generic version of Exelon
14-07-2017 Alembic Pharmaceutical inaugurates oncology manufacturing facility
10-07-2017 Alembic Pharmaceutical receives tentative approval for Dabigatran Etexilate Capsules, 150 mg
03-03-2017 Alembic Pharmaceuticals announces launch of desvenlafaxine succinate ER tablets
21-06-2017 Alembic Pharmaceuticals gets ANDA approval for Candesartan Cilexetil Tablets
31-07-2017 Alembic Pharmaceuticals gets ANDA approval for Doxycycline Capsules
18-07-2017 Alembic Pharmaceuticals gets ANDA approval for Olmesartan Medoxomil and Amlodipine Tablets
18-11-2016 Alembic Pharmaceuticals gets ANDA approval for Telmisartan and Amlodipine Tablets
05-12-2016 Alembic Pharmaceuticals gets ANDA approval for Zolmitriptan Orally Disintegrating Tablets
04-07-2017 Alembic Pharmaceuticals gets tentative approval for Vardenafil Hydrochloride Orally Disintegrating T
18-08-2017 Alembic Pharmaceuticals intimates of disruption in plant at Constantine, Algeria
22-10-2012 Alembic Pharmaceuticals received final approval for Modfinil tablets
22-06-2017 Alembic Pharmaceuticals receives ANDA approval for Amantadine Hydrochloride Capsules
15-05-2017 Alembic Pharmaceuticals receives ANDA approval for Fenofibric Acid Delayed-Release Capsules
07-04-2017 Alembic Pharmaceuticals receives ANDA approval for Fluoxetine Hydrochloride Tablets
16-12-2016 Alembic Pharmaceuticals receives ANDA approval for Itraconazole Capsules
02-05-2016 Alembic Pharmaceuticals receives final approval for Lacosamide Tablets
25-04-2017 Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hy
05-07-2016 Alembic Pharmaceuticals receives tentative approval for Febuxostat Tablets
03-05-2013 Alembic Pharmaceuticals Recommends Dividend
12-04-2012 Alembic Pharmaceuticals to consider dividend
05-06-2014 Alembic Pharmaceuticals to hold AGM
26-09-2014 Alembic Pharmaceuticals to hold board meeting
21-04-2016 Alembic Pharmaceuticals to set up JV with Orbicular
27-04-2015 Board of Alembic Pharmaceuticals appoints directors
10-01-2017 Board of Alembic Pharmaceuticals to consider Q3 results
28-07-2014 Outcome of board meeting of Alembic Pharmaceuticals

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
21-08-2017 3425 6064 56.48 1761135 3137.56
18-08-2017 732 2664 27.48 377383 1382.49
17-08-2017 1291 2456 52.57 663316 1273.57
16-08-2017 1442 2792 51.65 742703 1453.37
14-08-2017 1527 3187 47.91 793201 1658.84


Bulk Deals
Deal Date Client Name Type Qty Price
23-03-2017 SHRENO LI B 1000000 595.00
23-03-2017 VIRAMYA P S 1000000 595.00


Block Deals
Deal Date Client Name Type Qty Price
24-03-2017 SIERRA INVESTMENTS LIMITED B 170000 602.00
24-03-2017 SHRENO LIMITED B 530000 602.00
24-03-2017 VIRAMYA PACKLIGHT LLP S 170000 602.00
24-03-2017 VIRAMYA PACKLIGHT LLP S 530000 602.00
23-03-2017 SHRENO LI B 1000000 595.00


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  suga  •  lars  •  shree renuka sugar  •  ibre  •  tvs elect
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech